Fortecortin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Fortecortin
Health Canada Patents

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Symbiotec Dexamethasone

Contact Supplier

Chirogate is a professional Prostaglandin manufacturer.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Dexamethasone

Contact Supplier

jdmfs-not-supported-m-2025-06-30

Fortecortin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

95 API Suppliers, 27 USDMF, 12 CEP/COS, 6 JDMF, 4 EU WC, 7 KDMF, 26 NDC API, 1 VMF, 55 Listed Suppliers, $ API Reference Price

95 API Suppliers
27 USDMF
12 CEP/COS
6 JDMF
4 EU WC
7 KDMF
26 NDC API
1 VMF
55 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

236 Drugs in Development

236 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

365 FDF Dossiers, 130 FDA Orange Book, 113 Europe, 26 Canada, 10 Australia, 16 South Africa, 70 Listed Dossiers

365 FDF Dossiers
130 FDA Orange Book
113 Europe
26 Canada
10 Australia
16 South Africa
70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%, SUSPENSION/DROPS;OTIC - 0.3%;0.1%, OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%, TABLET;ORAL - 0.5MG, TABLET;ORAL - 0.75MG, TABLET;ORAL - 1.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 4MG, TABLET;ORAL - 6MG, SOLUTION;ORAL - 0.5MG/5ML, ELIXIR;ORAL - 0.5MG/5ML

SUSPENSION/DROPS;OPHTHALMIC - 0.1%
SUSPENSION/DROPS;OTIC - 0.3%;0.1%
OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%
OINTMENT;OPHTHALMIC - 0.1%;0.3%
SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%
TABLET;ORAL - 0.5MG
TABLET;ORAL - 0.75MG
TABLET;ORAL - 1.5MG
TABLET;ORAL - 1MG
TABLET;ORAL - 2MG
TABLET;ORAL - 4MG
TABLET;ORAL - 6MG
SOLUTION;ORAL - 0.5MG/5ML
ELIXIR;ORAL - 0.5MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 7 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 3 CD Formulation, 10 Corel Pharma Chem, 1 Curia, 6 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 15 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

52 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 29 Thickeners and Stabilizers, 28 Direct Compression, 26 Solubilizers, 22 Topical, 21 Granulation, 21 Parenteral, 18 Controlled & Modified Release, 18 Film Formers & Plasticizers, 17 Taste Masking, 17 Disintegrants & Superdisintegrants, 12 Rheology Modifiers, 12 Lubricants & Glidants, 12 Co-Processed Excipients, 9 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 5 API Stability Enhancers, 5 Empty Capsules, 4 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

52 Fillers, Diluents & Binders
41 Coating Systems & Additives
29 Thickeners and Stabilizers
28 Direct Compression
26 Solubilizers
22 Topical
21 Granulation
21 Parenteral
18 Controlled & Modified Release
18 Film Formers & Plasticizers
17 Taste Masking
17 Disintegrants & Superdisintegrants
12 Rheology Modifiers
12 Lubricants & Glidants
12 Co-Processed Excipients
9 Chewable & Orodispersible Aids
7 Emulsifying Agents
5 API Stability Enhancers
5 Empty Capsules
4 Surfactant & Foaming Agents
4 Vegetarian Capsules
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 272 News #PharmaBuzz

3 Data Compilation #PharmaFlow
272 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 110 Regulatory FDF Prices, 7 Annual Reports

39 US Medicaid Prescriptions
110 Regulatory FDF Prices
7 Annual Reports

MARKET PLACE

66 APIs, 59 FDF Dossiers

66 APIs
59 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 2 US Exclusivities, 3 Health Canada Patents

18 US Patents
2 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 6 USP, 2 JP, 8 Others

8 EDQM
6 USP
2 JP
8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 661 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 2AbbVie Corporation

02 1Gowling WLG (Canada) LLP

filter Patent Reset all filters

3 All

01 12414680

02 12429998

03 12512315

filter Product Reset all filters

3 All

01 3Dexamethasone

filter Dosage Reset all filters

3 All

01 3Intravitreal injection

filter Exp Date Reset all filters

3 All

01 12021-07-03

02 12021-11-28

03 12024-01-07

Product Main Page

01

AbbVie Corporation

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-11-28

Date Granted : 2012-01-17

Dexamethasone

Brand Name : OZURDEX

Patent Number : 2429998

Filing Date : 2001-11-28

Strength per Unit : 0.7 mg

Dosage Form : Intravitreal injection

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2021-11-28

Date Granted : 2012-01-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-07-03

Date Granted : 2007-09-18

Dexamethasone

Brand Name : OZURDEX

Patent Number : 2414680

Filing Date : 2001-07-03

Strength per Unit : 0.7 mg

Dosage Form : Intravitreal injection

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2021-07-03

Date Granted : 2007-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AbbVie Corporation

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-01-07

Date Granted : 2008-12-30

Dexamethasone

Brand Name : OZURDEX

Patent Number : 2512315

Filing Date : 2004-01-07

Strength per Unit : 0.7 mg

Dosage Form : Intravitreal injection

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2024-01-07

Date Granted : 2008-12-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!